Medindia

X

Loss of weight

by Medindia Content Team on  April 3, 2002 at 4:06 PM General Health News   - G J E 4
Loss of weight
The European Medicines Evaluation Agency (EMEA) committee that its scientific committee had initiated a review on the risks and benefits of the anti-obesity drug sibutramine. The drug is sold as Reductil in Europe and Meridia in the United States.
Advertisement

The drug was temporarily withdrawn from the market in Italy after reports that two patients taking the drug had died. A spokesman declined to say who was leading the review, which was requested by Italy.

Advertisement
Abbott, the manufacturer of sibutramine, has said it is aware of 34 deaths globally in patients taking the drug, but insists there is no evidence that the drug was the cause of the deaths.Millions of patients have taken the drug since it was launched in 1997.

Advertisement

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
Notify me when reply is posted I agree to the terms and conditions

You May Also Like

Advertisement
View All

More News on: